Parathyroid hormone-related protein protects renal tubuloepithelial cells from apoptosis by activating transcription factor Runx2

Kidney International

Volumn 83, Issue 5, 2013, Pages 825-834

  Ardura, Juan A ^a   Sanz, Ana B ^b   Ortiz, Alberto ^c   Esbrit, Pedro ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

apoptosis; PTHrP; Runx2; tubular epithelial cells

Indexed keywords

FOLIC ACID; MESSENGER RNA; OSTEOPONTIN; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN[1-34]; PARATHYROID HORMONE RELATED PROTEIN[1-36]; PROTEIN BCL 2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; URETER OBSTRUCTION;

EID: 84877070447     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.476     Document Type: Article

References (68)

1. Speck NA, Terryl S. A new transcription factor family associated with human leukemias. Crit Rev Eukaryot Gene Expr 1995; 5: 337-364.
2. Ducy P, Zhang R, Geoffroy V et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
3. Karsenty G, Ducy P, Starbuck M et al. Cbfa1 as a regulator of osteoblast differentiation and function. Bone 1999; 25: 107-108.
4. Banerjee C, Hiebert SW, Stein JL et al. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 1996; 93: 4968-4973.
5. Banerjee C, McCabe LR, Choi JY et al. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem 1997; 66: 1-8.
6. Shore P. A role for Runx2 in normal mammary gland and breast cancer bone metastasis. J Cell Biochem 2005; 96: 484-489.
7. Inman CK, Shore P. The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem 2003; 278: 48684-48689.
8. Fowler M, Borazanci E, McGhee L et al. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem 2006; 97: 1-17.
9. Komori T, Yagi H, Nomura S et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-764.
10. Bellido T, Ali AA, Plotkin LI et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003; 278: 50259-50272.
11. Sato M, Morii E, Komori T et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998; 17: 1517-1525.
12. Ophascharoensuk V, Giachelli CM, Gordon K et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 1999; 56: 571-580.
13. Ghiotto F, Fais F, Bruno S. BH3-only proteins: the death-puppeteer's wires. Cytometry A 2010; 77: 11-21.
14. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000; 19: 615-622.
15. Xie Y, Sakatsume M, Nishi S et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001; 60: 1645-1657.
16. Denhardt DT, Noda M, O'Regan AW et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-1061.
17. Jilka RL, Weinstein RS, Bellido T et al. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999; 104: 439-446.
18. Sanz AB, Santamaŕa B, Ruiz-Ortega M et al. Mechanisms of renal apoptosis in health and disease. J Am Soc Nephrol 2008; 19: 1634-1642.
19. Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 2002; 11: 301-308.
20. Hammerman MR. Growth factors and apoptosis in acute renal injury. Curr Opin Nephrol Hypertens 1998; 7: 419-424.
21. Ortega A, Rámila D, Ardura JA et al. Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 2006; 17: 1594-1603.
22. Ardura JA, Berruguete R, Rámila D et al. Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney. Am J Physiol Renal Physiol 2008; 295: F415-F425.
23. Gensure RC, Gardella TJ, Juppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 2005; 328: 666-678.
24. Philbrick WM, Wysolmerski JJ, Galbraith S et al. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 1996; 76: 127-173.
25. Ureñ a P, Kong XF, Abou-Samra AB et al. Parathyroid hormone (PTH)/PTHrelated peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993; 133: 617-623.
26. Dean T, Vilardaga JP, Potts JT Jr et al. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 2008; 22: 156-166.
27. Horwitz MJ, Tedesco MB, Gundberg C et al. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 2003; 88: 569-575.
28. Horwitz MJ, Tedesco MB, Sereika SM et al. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 2003; 88: 1603-1609.
29. Alonso V, de Gortázar AR, Ardura JA et al. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2. J Cell Physiol 2008; 217: 717-727.
30. Alonso V, Pérez-Martínez FC, Calahorra FJ et al. Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. Life Sci 2009; 85: 421-430.
31. Banerjee C, Javed A, Choi JY et al. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 2001; 142: 4026-4039.
32. Wang BL, Dai CL, Quan JX et al. Parathyroid hormone regulates osterix and Runx2 mRNA expression predominantly through protein kinase A signaling in osteoblast-like cells. J Endocrinol Invest 2006; 29: 101-108.
33. Kim S, Koga T, Isobe M et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 2003; 17: 1979-1991.
34. Justo P, Lorz C, Sanz A et al. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 2003; 14: 3072-3080.
35. Justo P, Sanz AB, Egido J et al. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005; 54: 2424-2429.
36. Lorz C, Justo P, Sanz A et al. Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 2004; 15: 380-389.
37. Lorz C, Justo P, Sanz AB et al. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int 2005; 67: 592-601.
38. Reed JC, Miyashita T, Takayama S et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. Cell Biochem 1996; 60: 23-32.
39. Rámila D, Ardura JA, Esteban V et al. Parathyroid hormone-related protein promotes inflammation in the mouse obstructed kidney. Kidney Int 2008; 73: 835-847.
40. Ducy P, Starbuck M, Priemel M et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999; 13: 1025-1036.
41. Sun L, Vitolo M, Passaniti A. Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion. Cancer Res 2001; 61: 4994-5001.
42. Pratap J, Lian JB, Javed A et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 2006; 25: 589-600.
43. Baniwal SK, Khalid O, Gabet Y et al. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer 2010; 9: 258.
44. Barnes GL, Javed A, Waller SM et al. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 2003; 63: 2631-2637.
45. Lin DL, Tarnowski CP, Zhang J et al. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. Prostate 2001; 47: n212-n221.
46. Pratap J, Javed A, Languino LR et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 2005; 25: 8581-8591.
47. Zelzer E, Glotzer DJ, Hartmann C et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001; 106: 97-106.
48. Ardura JA, Rayego-Mateos S, Rámila D et al. Parathyroid hormone-related protein promotes epithelial-mesenchymal transition. J Am Soc Nephrol 2010; 21: 237-248.
49. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
50. Zekri J, Ahmed N, Coleman RE et al. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 2001; 19: 379-382.
51. Eliseev RA, Dong YF, Sampson E et al. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene 2008; 27: 3605-3614.
52. Ho WP, Chan WP, Hsieh MS et al. Runx2-mediated bcl-2 gene expression contributes to nitric oxide protection against hydrogen peroxide-induced osteoblast apoptosis. J Cell Biochem 2009; 108: 1084-1093.
53. Pratap J, Imbalzano KM, Underwood JM et al. Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression. Cancer Res 2009; 69: 6807-6814.
54. Krishnan V, Moore TL, Ma YL et al. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol 2003; 17: 423-435.
55. Schlü ter KD. PTH and PTHrP: similar structures but different functions. News Physiol Sci 1999; 14: 243-249.
56. Ferrandon S, Feinstein TN, Castro M et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 2009; 5: 734-742.
57. Ortiz A, Lorz C, Justo P et al. Contribution of apoptotic cell death to renal injury. J Cell Mol Med 2001; 5: 18-32.
58. Scorrano L, Oakes SA, Opferman JT et al. BAX and BAK regulation of endoplasmic reticulum Ca2\+: a control point for apoptosis. Science 2003; 300: 135-139.
59. Tou L, Quibria N, Alexander JM. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Mol Cell Endocrinol 2003; 205: 121-129.
60. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 1996; 16: 5546-5556.
61. Grad JM, Zeng XR, Boise LH. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr Opin Oncol 2000; 12: 543-549.
62. Dai J, Peng L, Fan K et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009; 28: 3412-3422.
63. Song G, Ouyang G, Mao Y et al. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Aktmediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med 2009; 13: 1706-1718.
64. Garća-Ocañ a A, Galbraith SC, van Why SK et al. Expression and role of parathyroid hormone-related protein in human renal proximal tubule cells during recovery from ATP depletion. J Am Soc Nephrol 1999; 10: 238-244.
65. Esteban V, Lorenzo O, Rupérez M et al. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004; 15: 1514-1529.
66. Santos S, Bosch RJ, Ortega A et al. Up-regulation of parathyroid hormonerelated protein in folic acid-induced acute renal failure. Kidney Int 2001; 60: 982-995.
67. Ortiz A, Lorz C, Catalán MP et al. Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int 2000; 57: 969-981.
68. Fiaschi-Taesch NM, Santos S, Reddy V et al. Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 2004; 15: 112-125.